From Hypertension to Heart Failure

  • Michael Böhm
  • John H. Laragh
  • Manfred Zehender

Table of contents

  1. Front Matter
    Pages I-XIII
  2. Introduction

  3. Hypertension

  4. Angina Pectoris

    1. Front Matter
      Pages 57-57
    2. Ralph Haberl, Gerhard Steinbeck
      Pages 73-89
  5. Heart Failure

    1. Front Matter
      Pages 127-127
    2. Petra Schnabel, Markus Flesch, Michael Böhm
      Pages 159-176
    3. C. Maack, M. Böhm
      Pages 177-205
    4. Philip A. Poole-Wilson
      Pages 207-232
  6. Case Reports

    1. Front Matter
      Pages 233-233
    2. D. Hartmann, A. Stäblein
      Pages 243-248
  7. Back Matter
    Pages 249-258

About this book


Arterial hypertension, coronary heart disease and heart fail­ ure are the commonest cardiovascular conditions to present in clinical practice. Over the past few years it has become in­ creasingly clear that they are closely and causally interrelated and that their relationship can have a significant bearing on prognosis. Epidemiological studies have shown that arterial hypertension is one of the most important risk factors for de­ veloping heart failure. Only one in four patients with hyper­ tension is adequately managed, and in 50% of cases, the hypertension has not been recognised or treated. Patients with pre-existing hypertension who go on to suffer an acute myocardial infarction have usually not previously had typi­ cal angina symptoms, the infarct territory is larger, life threatening arrhythmias are commoner and hence in-hospi­ tal mortality and long-term prognosis are markedly worse. The presence of raised blood pressure in the post-infarct phase doubles the risk of manifest heart failure. The close relationship between hypertension, coronary heart disease and heart failure makes the choice of therapeu­ tic strategy particularly important. Agents and classes of agents that have prognostic value in all three conditions should be considered first, as synergy might result in addi­ tional benefits. In such patients, this sort of therapeutic deci­ sion-making might have further advantages. The use of these agents may prevent complications which are not yet clinically obvious (such as heart failure).


angina pectoris cardiovascular coronary artery disease heart hypertension sudden cardiac death

Editors and affiliations

  • Michael Böhm
    • 1
  • John H. Laragh
    • 2
  • Manfred Zehender
    • 3
  1. 1.Klinik III für Innere Medizin der Universität KölnKölnGermany
  2. 2.Cornell Medical CenterThe New York HospitalNew YorkUSA
  3. 3.Abteilung Innere Medizin IIIMed. Universitätsklinik und PoliklinikFreiburgGermany

Bibliographic information

  • DOI
  • Copyright Information Springer-Verlag Berlin Heidelberg 1998
  • Publisher Name Springer, Berlin, Heidelberg
  • eBook Packages Springer Book Archive
  • Print ISBN 978-3-540-63542-0
  • Online ISBN 978-3-642-60300-6
  • Buy this book on publisher's site